Eto's allegations center on Mayo Clinic leadership bypassing institutional review boards, mishandling patient data during de-identification, and approving medical procedures without proper oversight. She specifically claims the health system concealed a 67% error rate in its MAYA digital assistant tool by deleting unflattering test results and misrepresenting the tool's capabilities. The complaint also alleges manipulation of the patent process for her "AI Protocol Builder" concept and use of an internal "ghost file" system to mark her as ineligible for rehire. The full scope of Mayo Clinic's response and any internal investigation findings remain undisclosed.
For healthcare counsel, this case signals emerging litigation risk around AI implementation and whistleblower protections in medical settings. The specific allegations of data mishandling and suppressed error rates during clinical tool deployment raise immediate questions about institutional compliance with FDA guidance and state medical board standards. Attorneys should monitor discovery for patterns in how health systems document AI validation, handle adverse findings, and respond to internal safety concerns—issues likely to surface in regulatory inquiries and future litigation as AI adoption accelerates across healthcare.